Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04701619 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Immuno-inflammatory Profile and Response to Ischemic Stroke Reperfusion Therapies (IMMUNOSTROKE)

Study acronym: IMMUNOSTROKE
StatusNot Yet Recruiting
PhaseNot applicable
Started2026-09-15
View on ClinicalTrials.gov ↗

Amendment history

2026-01-16
Study Status, Oversight, Eligibility, Contacts/Locations, IPDSharing v12
Eligibility criteria+451 characters
Inclusion Criteria: Patient over 18 years of age Presenting with an ISCHEMIC STROKEACS for which reperfusion treatmenttherapy is indicated according to European and North American recommendations (intraveinousIV thrombolysis or mechanical thrombectomy or a combination of both) Having received informed information about the study and having signed a consent form to participate in the study (if this is not possible: information and consent from a trusted person or family member if present; emergency inclusion if absent) Affiliated with or beneficiary of a social security sy [...] Exclusion Criteria: Co [...] [...]
2025-06-19
Study Status, Oversight, IPDSharing v11
Primary completion date2025-10-15→2027-10-15
Completion date2026-05-15→2028-05-15
Start date2024-09-15→2026-09-15
2024-06-05
Study Status v10
Start date2024-04-15→2024-09-15
2024-02-15
Study Status v9
Start date2024-01-15→2024-04-15
2023-11-20
Study Status v8
Start date2023-10-15→2024-01-15
Show 7 earlier versions
2023-07-06
Study Status v7
Primary completion date2025-05-15→2025-10-15
Completion date2025-12-15→2026-05-15
Start date2023-05-15→2023-10-15
2023-02-14
Study Status v6
Primary completion date2023-04-15→2025-05-15
Completion date2024-12-15→2025-12-15
Start date2022-10-15→2023-05-15
2022-04-21
Study Status v5
Primary completion date2023-08-15→2023-04-15
Completion date2024-07-15→2024-12-15
Start date2022-02-15→2022-10-15
2021-12-23
Study Status v4
Primary completion date2022-05-15→2023-08-15
Completion date2023-04-15→2024-07-15
Start date2021-10-15→2022-02-15
2021-08-02
Study Status v3
Primary completion date2022-01-15→2022-05-15
Completion date2023-01-15→2023-04-15
Start date2021-06-15→2021-10-15
2021-05-25
Study Status v2
Start date2021-04-15→2021-06-15
2021-03-03
Study Status v1
Start date2021-01-15→2021-04-15
2021-01-07
Original filing
IMMUNOSTROKE study aims to describe the immuno-inflammatory and thrombo-inflammatory profiles during the course of AIC management by reperfusion treatment and to monitor changes in these different parameters over time. Post-hoc analyses will make it possible to correlate the immuno-inflammatory and thrombo-inflammatory profiles and their evolution with the clinical outcome in terms of post-AIC functional and cognitive disability.
Trial Details
NCT Number NCT04701619
Lead Sponsor Fondation Ophtalmologique Adolphe de Rothschild
Conditions Stroke, Ischemic Stroke
Enrollment 300 participants
Start Date 2026-09-15
Primary Completion 2027-10-15 (estimated)
Study Completion 2028-05-15 (estimated)
Updated on ClinicalTrials.gov 2026-01-20